X-Chem Acquires IntelliSyn and Sister Company, AviSyn, to Extend and Streamline Drug Discovery Service...
X-Chem, Inc. (X-Chem), the industry-leading provider of DNA-Encoded Library (DEL)-based discovery services, has acquired IntelliSyn,...
BioMed X Institute starts new research project in drug delivery in collaboration with Janssen
German independent research institute BioMed X announces its new research project with Janssen Research &...
Enara and Boehringer Ingelheim sign oncology partnership
Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against...
Nexelis acquires the GSK vaccines clinical bioanalytical laboratory located in Germany
Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay...
Lilly, Merus Ink Up-to-$1.6B Bispecific Antibody Partnership vs. Cancer
Eli Lilly’s oncology-focused Loxo Oncology at Lilly will partner with Merus to develop up to...
ConserV Bioscience and Lawrence Livermore National Laboratory to Collaborate on Development of Broad-spectrum Coronavirus...
ConserV Bioscience Limited (“ConserV”), a clinical-stage biotechnology company focused on developing vaccines that protect against...
Novartis and GSK announce collaboration to support scientific research into genetic diversity in Africa
Novartis and GSK announced the launch of a collaboration to support high-quality scientific research investigating...
Grifols begins clinical trial of a new treatment that would provide immediate immunity against...
Grifols, a global leader in the development of therapies with plasma-derived proteins with a track...
Thermo Fisher Scientific Extends SARS-CoV-2 GlobalAccess Sequencing Program to Support Research on New Virus...
As scientists continue to identify new strains of the SARS-CoV-2 virus, including the B.1.1.7 UK...
Lonza to Partner with Capricor Therapeutics for the Development of Duchenne Muscular Dystrophy Cell...
Lonza and Capricor Therapeutics, a US-based clinical-stage biotechnology company, announced on Jan. 12, 2020 that...
